Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05590741 · ClinicalTrials.gov registry record · NA
An Idiographic Examination of Treatment Mechanisms in Emotion Regulation Therapy
A NA study of Depression and Anxiety, sponsored by Teachers College, Columbia University.
- Active
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT05590741: Active NA study of Depression and Anxiety, sponsored by Teachers College, Columbia University.
NCT05590741 is a NA study of Depression and Anxiety that is active but no longer recruiting, run by Teachers College, Columbia University. The registered enrollment target is 24 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05590741, a NA study of Depression and Anxiety, is active but no longer recruiting, sponsored by Teachers College, Columbia University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is an open trial designed to examine individual changes that occur before, during, and after 12 sessions of Emotion Regulation Therapy (ERT) delivered via telehealth for individuals in New York State who are experiencing elevated worry, rumination, or self-criticism.
Conditions Studied
Interventions
- BEHAVIORAL Emotion Regulation Therapy via Telehealth
Study Locations (1)
New York
- Teachers College, Columbia University - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2022-11-16 |
| Est. Completion | 2025-11 |
| Phase | NA |
What the registry record for NCT05590741 still lists
NCT05590741 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (97% lower).
The record links to 6 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Emotion Regulation Therapy via Telehealth is the first listed.
NCT05590741 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05590741 about?
NCT05590741 is a clinical study titled "An Idiographic Examination of Treatment Mechanisms in Emotion Regulation Therapy". This study is an open trial designed to examine individual changes that occur before, during, and after 12 sessions of Emotion Regulation Therapy (ERT) delivered via telehealth for individuals in New York State who are experiencing elevated worry, rumination, or self-criticism.
What is the current status of trial NCT05590741?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2022-11-16. Estimated completion is 2025-11.
What conditions does trial NCT05590741 study?
This clinical trial studies the following conditions: Depression, Anxiety, Distress, Emotional, Rumination, Worry.
What interventions are being tested in trial NCT05590741?
The interventions under investigation include: Emotion Regulation Therapy via Telehealth (BEHAVIORAL).
Who is sponsoring clinical trial NCT05590741?
This trial is sponsored by Teachers College, Columbia University, which has 25 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05590741 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05590741's enrollment target sits among peer trials
24 594th of 679 higher than 79 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy